Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.837995
Abstract: T cells engineered with chimeric antigen receptors (CAR) have demonstrated its widespread efficacy as a targeted immunotherapeutic modality. Yet, concerns on its specificity, efficacy and generalization prevented it from being established into a first-line approach…
read more here.
Keywords:
cold atmospheric;
onco immunotherapy;
car therapies;
atmospheric plasma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecules"
DOI: 10.3390/molecules27123807
Abstract: Compromised activity is a common impediment for biologics requiring endosome trafficking into target cells. In cancer cells, antibody-drug conjugates (ADCs) are trapped in endosomes or subsequently pumped extracellularly, leading to a reduction in intracellular accumulation.…
read more here.
Keywords:
novel conjugable;
immunotherapy;
onco immunotherapy;
accum technology ... See more keywords